Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) FCF Margin (2018 - 2025)

Historic FCF Margin for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to 16.74%.

  • Abvc Biopharma's FCF Margin fell 322100.0% to 16.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 523.45%, marking a year-over-year decrease of 2218600.0%. This contributed to the annual value of 355.02% for FY2024, which is 24056200.0% up from last year.
  • Latest data reveals that Abvc Biopharma reported FCF Margin of 16.74% as of Q3 2025, which was down 322100.0% from 690.95% recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's FCF Margin ranged from a high of 690.95% in Q2 2025 and a low of 79320.83% during Q1 2024
  • Its 5-year average for FCF Margin is 9324.04%, with a median of 1167.54% in 2023.
  • In the last 5 years, Abvc Biopharma's FCF Margin crashed by -781532900bps in 2024 and then surged by 795505900bps in 2025.
  • Quarter analysis of 5 years shows Abvc Biopharma's FCF Margin stood at 641.43% in 2021, then plummeted by -112bps to 78.3% in 2022, then crashed by -25294bps to 19882.82% in 2023, then tumbled by -80bps to 35713.84% in 2024, then surged by 100bps to 16.74% in 2025.
  • Its last three reported values are 16.74% in Q3 2025, 690.95% for Q2 2025, and 229.76% during Q1 2025.